Abstract
Aim
The purpose of this study is to compare maternal outcomes in patients with placenta accreta spectrum (PAS) when managed as part of a multi-disciplinary team (MDT) compared to standard care.
Methods
Patients in the standard care group were retrospectively identified from pathology records, with patients in the MDT group prospectively collected on an electronic database. Data on maternal demographics, delivery, estimated blood loss (EBL), transfusion requirements, and morbidity were recorded.
Results
Sixty patients were diagnosed with PAS between 2006 and 2019, of whom 32 were part of the standard care group and 28 in the MDT group. Compared to standard care, MDT care was associated with an increase in antenatal diagnosis from 56.3 to 92.9% (p < 0.0001), a significant reduction in EBL (4150 mL (800–19500) vs 1975 (495–8500), p < 0.0001), and transfusion requirements (median 7 (0–30) units of RCC vs 1 (0-13), p < 0.0001).
Conclusion
PAS is associated with significant maternal morbidity and warrants management in an MDT setting with specialist input, which is associated with improved outcomes.
Similar content being viewed by others
Abbreviations
- PAS:
-
Placenta accreta spectrum
- MDT:
-
Multidisciplinary team
- EBL:
-
Estimated blood loss
References
Jauniaux E, Chantraine F, Silver RM et al (2018) FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet 140:265
Bartels HC, Postle JD, Downey P, Brennan DJ (2018) Placenta accreta spectrum: A review of pathology, molecular biology, and biomarkers. Dis Markers 2018, Article ID 1507674:11
Publications Committee, Society for Maternal-Fetal Medicine, Belfort MA Placenta accreta (2010) Am J Obstet Gynecol 203(5):430–439. https://doi.org/10.1016/j.ajog.2010.09.013
O’Brien JM, Barton JR, Donaldson ES (1996) The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 175:1632–1638
Knight M, Nair M, Tuffnell D, Shakespeare J, Kenyon S, Kurinczuk JJ, on behalf of MBRRACE-UK (eds) (2017) Saving Lives, Improving Mothers’ Care - Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2013–15. National Perinatal Epidemiology Unit, University of Oxford, Oxford
Stotler B et al (2011 Dec) Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 51(12):2627–2633
World Health Organization (WHO) (2016) Maternal mortality. http://www.who.int/mediacentre/factsheets/fs348/en/. Accessed 24 Oct 2016
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, Gülmezoglu AM, Temmerman M, Alkema L (2014) Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health 2(6):e323–e333
Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S, Jurkovic D,Kayem G, Kingdom J, Silver R, Sentilhes L on behalf of the Royal College of Obstetricians and Gynaecologists. PlacentaPraevia and placenta accreta: Diagnosis and Management. Green-top Guideline No. 27a. BJOG 201
Hung T-H, Shau W-Y, Hsieh C-C et al (1999) Risk factors for placenta accreta. Obstet Gynecol 93:545–50. 20
Wu S, Kocherginsky M, Hibbard JU (2005) Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 192:1458–1146
Read JA, Cotton DB, Miller FC (1980) Placenta accreta: changing clinical aspects and outcome. Obstet Gynecol 56:31–34
Mogos MF, Salemi JL, Ashley M, Whiteman VE, Salihu HM (2016) Recent trends in placenta accreta in the United States and its impact on maternal-fetal morbidity and healthcare-associated costs, 1998-2011. J Matern Fetal Neonatal Med 29:1077–1082
Bartels HC, Rogers AC, O’Brien D, Brennan DJ (2018) Association of implementing a multidisciplinary team approach in the management of morbidly adherent placenta with maternal morbidity and mortality. Obstet Gynecol 132(5):1167–1176
Jauniaux ERM, Alfirevic Z, Bhide AG, Belfort MA, Burton GJ, Collins SL, Dornan S, Jurkovic D,Kayem G, Kingdom J, Silver R, Sentilhes L on behalf of the Royal College of Obstetricians and Gynaecologists. PlacentaPraevia and Placenta Accreta: Diagnosis and Management. Green-top Guideline No. 27a. BJOG 2018
Solheim KN, Esakoff TF, Little SE, Cheng YW (2011) Sparks TN, Caughey AB. The effect of cesarean delivery rates on the future incidence of placenta previa, placenta accreta, and maternal mortality. J Matern Fetal Neonatal Med 24(11):1341–6. https://doi.org/10.3109/14767058.2011.553695
Dindo et al (2004) Classification of surgical complications A new proposal with evaluation in a cohort of 6336. Patients and results of a survey. Ann Surg 240(2):205–213
Brennan DJ, Schulze B, Chetty N, Crandon A (2015) Surgical management of abnormally invasive placenta: a retrospective cohort study demonstrating the benefits of a standardized operative approach. AOGS 94(12):1380–1386
Mullen C, Battarbee AN, Ernst LM, Peaceman AM (2019 April) Occult placenta accreta risk factors, adverse obstetrical outcomes, and recurrance in subsequent pregnancies. Am J Perinatol 36(5):472–475
Eller et al (2011) Maternal morbidity in cases of placenta accreta managed by a multidisciplinary care team compared with standard obstetric care. Obstet Gynecol 117:331–337
Smulian JC, Pascual A-L, Hesham H, Emma Q, Bijoy Thomas M, Depuy AM, Flicker AB, Scorza WE (2017) Invasive placental disease: the impact of a multi-disciplinary team approach to management. J Matern Fetal Neonatal Med 30(12):1423–1427. https://doi.org/10.1080/14767058.2016.1216099
Melcer Y et al (2018) Impact of targeted scanning protocols on perinatal outcomes in pregnancies at risk of placenta accreta spectrum or vasa previa. Am J Obstet Gynecol 218(4):443.e1–443.e8
Al-Khan A, Gupta V, Illsley NP et al (2014) Maternal and fetal outcomes in placenta accreta after institution of team-managed care. Reprod Sci 21(6):761–771. https://doi.org/10.1177/1933719113512528
Lekic Z, Ahmed E, Peeker R et al (2017) Striking decrease in blood loss with a urologist-assisted standardized multidisciplinary approach in the management of abnormally invasive placenta. Scand J Urol 51(6):491–495. https://doi.org/10.1080/21681805.2017.1352617
Shamshirsaz AA et al (2017) Multidisciplinary team learning in the management of the morbidly adherent placenta: outcome improvements over time. Am J Obstet Gynecol 216(6):612.e1–612.e5
Shamshirsaz AA, Fox KA, Erfani H (2018) Outcomes of planned compared with urgent deliveries using a multidisciplinary team approach for morbidly adherent placenta. Obstet Gynecol 131:234–241
Whiteman MK, Kuklina E, Hillis SD et al (2006) Incidence and determinants of peripartum hysterectomy. Obstet Gynecol 108:1486–1492
Eller et al (2009) Optimal management strategies for placenta accreta. BJOG 116(5):648–654. https://doi.org/10.1111/j.1471-0528.2008.02037.x
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The authors declare that they have no conflict of interest. All authors who contributed to the manuscript are named authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Key message
Maternal outcomes are significantly improved in placenta accreta spectrum when managed by a multidisciplinary team in a specialist center. Antenatal diagnosis, elective pre-term delivery, and a standardized surgical approach contribute to improved maternal outcomes.
Rights and permissions
About this article
Cite this article
Bartels, H.C., Mulligan, K.M., Craven, S. et al. Maternal morbidity in placenta accreta spectrum following introduction of a multi-disciplinary service compared to standard care: an Irish perspective. Ir J Med Sci 190, 1451–1457 (2021). https://doi.org/10.1007/s11845-020-02473-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-020-02473-3